Amorsa Therapeutics, Inc. Email Format
Pharmaceutical ManufacturingMassachusetts, United States0-1 Employees
Amorsa Therapeutics, Inc. is a Southborough, Massachusetts-based company in the pharmaceutical manufacturing space focused on developing novel, patented ketamine analogs for neuropsychiatric disorders. Its work targets treatment-resistant depression, PTSD, and obsessive-compulsive disorder, with the goal of expanding options where current therapies may be insufficient. The organization advances small molecule candidates derived from its ketamine-analog technology. In May 2018, Amorsa appointed Jeffrey Wiesen to its Board of Directors. Previously, the company pursued a research, option and license agreement with Janssen Pharmaceuticals to develop and commercialize a novel ketamine-analog drug candidate for treatment-resistant depression.